Home > Insider Trading > Filing (0001708138-20-000043)

Filing Details

Accession Number:: 0001708138-20-000043
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-20 19:27:35
Reporting Period:: 2020-04-16

Accepted Time:: 2020-04-20 19:27:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238303	J Joseph Larosa	777 Old Saw Mill River Road Tarrytown NY 10591	Evp General Counsel And Secret	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-04-20	669	$567.30	15,547	No	4	S	Direct
Common Stock	Disposition	2020-04-20	234	$569.41	15,313	No	4	S	Direct
Common Stock	Disposition	2020-04-20	125	$570.27	15,188	No	4	S	Direct
Common Stock	Disposition	2020-04-20	112	$571.65	15,076	No	4	S	Direct
Common Stock	Disposition	2020-04-20	61	$572.94	15,015	No	4	S	Direct
Common Stock	Disposition	2020-04-20	577	$573.59	14,438	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-04-16	5,000	$0.00	5,000	$59.20
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-04-17	6,622	$0.00	6,622	$59.20
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-04-17	5,000	$0.00	5,000	$59.20

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,933	2021-09-01	No	4	M	Direct
23,311	2021-09-01	No	4	M	Direct
18,311	2021-09-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	287	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 669 shares of Company stock on April 20, 2020 at prices ranging from $567.00 to $567.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
Represents volume-weighted average price of sales of 234 shares of Company stock on April 20, 2020 at prices ranging from $569.22 to $569.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
Represents volume-weighted average price of sales of 125 shares of Company stock on April 20, 2020 at prices ranging from $570.03 to $570.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
Represents volume-weighted average price of sales of 577 shares of Company stock on April 20, 2020 at prices ranging from $573.31 to $573.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Form two of two